With Direct-to-Patient Zepbound, Eli Lilly Takes a Stand Against Compounders and PBMs

Eli Lilly now offers vials of obesity medication Zepbound directly to self-pay patients at a nearly 50% discount off the drug’s list price. But more than offering patients a lower-cost alternative, this move represents a strategic stance against certain pharmaceutical industry players. The post With Direct-to-Patient Zepbound, Eli Lilly Takes a Stand Against Compounders and…

Read More

A Primer on Health Equity Research

According to the World Health Organization, “Three distinguishing features, when combined, turn mere variations or differences in health into a social inequity in health. They are systematic, socially produced (and therefore modifiable) and unfair. That is how an ISPOR Special Interest Group Report by Griffiths et al. (2025) begins. The health equity primer provides and…

Read More

Next Up: Fiber Computers

By KIM BELLARD I know: you’re pretty proud for being into “wearables” to help monitor your health and other functions. You’ve got some apps on your smartphone. You use a smartwatch. Maybe you’ve tried one of the many iterations of smart glasses, like Google Glass or Meta’s Ray Bans. You were disappointed when Humane’s AI…

Read More